Open original FDA record ↗Recall record
- FDA identifier
- Z-2671-2014
- Company in FDA record
- ORTHO-CLINICAL DIAGNOSTICS
- FDA classification date
- Sep 19, 2014
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
VITROS Immunodiagnostic Products Anti-HCV kit lot 9090 has been observed producing sporadic lower than expected VITROS Anti-HCV test results due to an approximate signal loss of up to 66.2% which can result in unexpected negative test results being obtained for reactive sample fluids (quality control and patient samples).
Source facts
- Action
- All US consignees (users) who were shipped the affected lot VITROS HCV Reagent Pack were sent communications via FedEx and/or US Priority Mail (PO Boxes only) on 8/06/14, and advised of the issue and to immediately discontinue using all remaining inventory of VITROS Anti-HCV Reagent Packs Lot 9090. For additional information, please contact OCD's Customer Technical Service representatives at 1-800-421-3311.
- Initiated
- 2014-08-06
- Root cause
- Packaging process control
- Terminated
- 2017-04-14
- Distribution
- NY, NJ, CT, MA, PA, VA, MD, FL and GA
- Recall number
- Z-2671-2014
- Recall status
- Terminated
- CDRH record ID
- 129189
- FDA classified
- 2014-09-19
- Recall event number
- 68974